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ABSTRACT 
 
Recent advancements in the ability to construct three-dimensional (3D) tissues and organoids from stem cells and 
biomaterials have not only opened abundant new research avenues in disease modeling and regenerative medicine 
but also have ignited investigation into important aspects of molecular diffusion in 3D cellular architectures. This 
paper describes fundamental mechanics of diffusion with equations for modeling these dynamic processes under a 
variety of scenarios in 3D cellular tissue constructs. The effects of these diffusion processes and resultant 
concentration gradients are described in the context of the major molecular signaling pathways in stem cells that both 
mediate and are influenced by gas and nutrient concentrations, including how diffusion phenomena can affect stem 
cell state, cell differentiation, and metabolic states of the cell. The application of these diffusion models and pathways 
is of vital importance for future studies of developmental processes, disease modeling, and tissue regeneration. 
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1. INTRODUCTION 
 
Life exists at the interface of numerous molecular, chemical, and physical processes, and as part of this precarious 
balance, life must both exploit and overcome various features of these phenomena. One of the most important 
physical processes that both defines and limits cellular functions in the human body is that of diffusion. Evidence 
suggests that diffusion of molecular factors may play vital roles in the self-organization of tissue architecture and 
determination of cellular identity in development, including factors affecting potency, differentiation, metabolic state, 
and functions of cells and tissues. Many of these developmental and metabolic processes and signaling pathways 
remain to be studied and elucidated, but the ability to mathematically model the role of diffusion processes with 
precise theoretical determinations opens a valuable and expansive field of mathematical study in stem cell biology, 
developmental biology, tissue engineering, and disease modeling.  
 
Recent major advancements in biomaterials and stem cell culture have enabled the construction of complex three-
dimensional (3D) multi-cellular organoid tissues. In some cases, cells are able to self-organize within a homogenous 
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biomaterial scaffold [1], in some cases the cellular architecture may be guided by more complex configurations of 
patterned topographical and biochemical cues within the construct [2], while in other cases cells may be grown into 
aggregate multi-cellular spheroids without the addition of biomaterials [3]. These organoid constructs enable 
incredible new capabilities for researching numerous biological processes in a controlled in vitro environment, 
including the study of organ development, stem cell growth and differentiation, and cell signaling factors involved in 
the formation of cellular identity and spatial patterning. Importantly, these organoid technologies also open up a vast 
number of clinical applications, including disease modeling, pharmacological and toxicological drug testing, tumor 
models that direct personalized chemotherapy, and tissue reconstruction for regenerative medicine. However, the 
formation of 3D cellular cultures also gives rise to new complexities in physical diffusion phenomena that are not 
present in more traditional two-dimensional (2D) culture systems and which warrant detailed examination.  
 
2. INTERACTIONS OF DIFFUSION PHENOMENA WITH STEM CELL FUNCTION AND TISSUE DEVELOPMENT 
 
2.1 The Emergence of Diffusion Phenomena in 3D Tissue Constructs 
 
With the formation of conglomerate cell cultures and engineered tissues, new diffusion dynamics arise in the 3D 
constructs. Delivery of nutrients like oxygen, glucose, fats, and amino acids to cells in such constructs is effectively 
more limited, which can critically affect in vitro tissue development as well as integration of the construct into the 
body after implantation. Diffusion-limited growth and inadequate mass transport of nutrients or signaling factors 
into the deeper or more sequestered regions of the construct tends to decrease cell survival and tissue size, and 
metabolism of the diffusant further decreases its availability and alters its spatial concentration profile through the 
construct [4]. The shape of the concentration gradient through a tissue is affected by the local conditions of the 
system, which is important because the shape of this gradient may produce differential downstream consequences on 
the development of stem cells based on their positioning within tissues. In addition, concentration gradients are also 
known to play important roles in axonal guidance, although much remains to be explored on the mechanisms of how 
such gradients are established at the proper place and time in tissues and how multiple gradients interact with each 
other to influence developing cells and tissue architecture. Thus modeling these mechanisms helps to understand 
both normal development and may also relate to previously unknown mechanisms of certain developmental 
pathologies. 
 
In general, there is a Gaussian-shaped curve through unbound space for limited and unmetabolized substances 
diffusing through a homogenous medium of any dimensionality, while an unmetabolized substance in constant or 
unlimited supply in tissue constructs will generally produce the shape of a complementary error function (erfc) when 
diffusing primarily in one dimension, the shape of a Bessel function of the first kind (order zero) when diffusing 
primarily in two dimensions, and the shape of a hyperbolic curve when diffusing in three dimensions [4]. The 
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introduction of constant (zero order) metabolism of the diffusant generally results in a parabolic concentration curve 
in any dimensionality [4]. Multiple different molecular factors can simultaneously overlap with entirely different 
concentration gradients depending on the conditions and characteristics of both the cellular tissue and each 
molecular factor. The initial concentration of diffusant at the tissue interface () will proportionally influence the 
concentration values throughout the tissue, while the diffusion coefficient () has a more complex role, 
proportionally relating the molar flux of diffusant to the spatial concentration gradient, which, in essence, ultimately 
describes how easily a particular diffusant moves through a medium. Diffusion limitations can be partially overcome 
through a variety of methods, which include the general approaches of increasing nutrient concentrations in 
surrounding fluid, decreasing the diffusion coefficient in the construct material (i.e., increasing permeability to 
nutrients), decreasing the diffusion range or depth of the tissue construct, increasing convective flow or perfusion of 
nutrient, or decreasing nutrient consumption, and each of these approaches has consequences for the tissue construct.  
 
Importantly, diffusion limitations can also be desirable, producing concentration gradients into or out of the tissue 
construct that mediate essential developmental processes and activate or inhibit vital cell signaling cues. It is known 
that diffusion gradients of numerous morphogenic signaling factors play extensive roles in the differentiation and 
architectural formation of neural tissue, including, for example, regional gradients of sonic hedgehog (SHH), wnt 
protein (WNT), bone morphogenic protein (BMP), fibroblast growth factor (FGF), retinoic acid (RA), and reelin 
(RELN) [5]. The limited diffusion capacity of biomaterials not only causes decreased concentration of externally-
supplied nutrients within the construct, but also results in increased internal concentrations of endogenous factors 
secreted by cells. This property of biomaterials enables endogenous signaling factors to form local regions of 
concentration gradients similar to what occurs in endogenous developing tissue, and this property likely provides 
essential self-organization capabilities of cells in 3D organoid constructs over standard 2D cultures under the same 
culture conditions. Thus, several analytic models are presented herein, including equations for both inward and 
outward diffusion, to describe diffusant behaviors and consequences in various 3D tissue constructs, as summarized 
in Figure 1. 
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Figure 1: Summary of Equations for Diffusion Modeling in 3D Tissue Constructs. Models of transient and steady-state diffusion in a variety of 
scenarios are provided, including for limited or unlimited diffusants, diffusion into or out of the tissue, with or without metabolism of the 
diffusant, and in constructs of slabs (1D – bottom row), cylinders (2D – middle row), or spheres (3D – top row). 
 
 
2.2 The Influence of Diffusing Factors on Cell Signaling Pathways, Metabolism, and Potency State 
 
Although much remains to be learned regarding the role of diffusing nutrients in tissue development, it has recently 
become apparent that metabolic dynamics and nutrient supply can control epigenetic configurations of stem cells, 
and reciprocally, epigenetic networks control energetic processes and metabolic preferences in the cell. Moreover, 
these effects can play a significant role in stem cell potency, differentiation, and fundamental programmed processes 
in tissue development. Evidence suggests that the metabolic activity of a cell is actively modified by many of the 
same epigenetic reconfigurations that occur through changing states of stem cell potency and differentiation, and in 
general, while mature cells tend to favor the efficiency of oxidative metabolism, pluripotent stem cells (PSCs) tend to 
favor a glycolytic state [6]. Many other types of stem cells, including neural stem cells (NSCs), also favor anaerobic 
glycolytic metabolism [7,8] while mature neurons favor oxidative metabolism [9,10]. The oxidative preference of 
adult somatic cells is converted to a glycolytic preference early in reprogramming to a pluripotent state [11,12,13], 
and this may be related to the observation that glycolysis is also favored by malignantly-transformed cells, which 
resemble stem cells in their self-renewal and ability to endure hypoxic environments [14,15,16]. In cancer cells, this 
shift in metabolism from aerobic to anaerobic appears to be actively instigated by mutated genes like tumor 
suppressor protein p53 (TP53) and its downstream targets [17,18]. Similarly, in both embryonic and induced stem 
cells, these metabolic preferences are not merely passive consequences, but are in fact requisite in maintaining the 
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pluripotent state and in reprogramming mature cells to a pluripotent state, and differentiation of pluripotent cells can 
be impeded unless these glycolytic processes switch to an oxidative metabolism [19,20,21].  
 
Expression of several glycolytic enzymes is upregulated under conditions of hypoxia [16,22]. It is thought that the 
preferred glycolytic state of stem cells or cancer cells may serve to protect them from reactive oxygen species (ROS)—
glycolysis enables the pentose phosphate pathway to produce the reduced form of nicotinamide adenine 
dinucleotide phosphate (NADPH), which keeps glutathione in a reduced state (GSH) for antioxidant protection [17]. 
Exposure of adult stem cells to ROS has been noted to prompt quiescent adult stem cells, including hematopoietic 
stem cells (HSCs), mesenchymal stem cells (MSCs), and neural stem cells (NSCs), out of quiescence and into 
proliferation [8], and exposure to ROS can also affect cell fate decisions [23,24]. Antioxidants like vitamin C can help 
reverse cell senescence and aid changes in epigenetic expression during reprogramming of induced pluripotent stem 
cells (iPSCs) [25]. The influence of a stem cell’s energy status and mitochondrial function on its potency state may 
also explain why supplementation with electron-carrier coenzymes like NAD+ precursor nicotinamide riboside has 
been found to rejuvenate neural and muscle stem cells [26]. In addition, despite less efficient energy production than 
oxidative phosphorylation, glycolysis and the pentose phosphate pathway also enable improved anabolic nutrient 
production for cell proliferation, including the synthesis of nucleotides, amino acids, and lipids [27].    
 
Several sensors of energy usage and nutrient availability exist in the cell, including adenosine monophosphate-
activated kinase (AMPK) and the mammalian target of rapamycin complex (mTORC). As adenosine triphosphate 
(ATP) energy is used, AMPK becomes activated by phosphorylation in order to inhibit anabolic processes that 
consume ATP and to activate catabolic processes that replenish ATP. Similarly, a low supply of amino acids will 
attenuate mTORC activity, which lowers anabolic activity in the cell. Under normoxic conditions, the 14-3-3 protein 
inhibits the tuberous sclerosis 2 protein (TSC-2), preventing expected inhibition of mTORC by the tuberous sclerosis 
protein 1/2 (TSC-1/2) complex. Hypoxia, however, upregulates REDD1 protein, which inhibits binding of the 14-3-3 
protein to the TSC-1/2 complex, thereby enabling inhibition of mTORC [8,28]. Activated AMPK (whether from low 
glucose or oxygen supply or from high energy usage that exceeds energy supply) can inhibit mTORC activity, 
thereby inhibiting protein production. Interestingly, reprogramming to pluripotency decreases mTORC activity, 
likely due to the fact that Sox2 represses mTORC expression [29]. Moreover, activation of mTORC (e.g., by deletion of 
TSC-2) inhibits reprogramming to pluripotency, while inhibition of mTORC (e.g., with rapamycin) enhances 
reprogramming to a pluripotent state, and the inhibition of mTORC has also been shown to help maintain the 
population of stem cells and to suppress the production of ROS [8,30]. It should also be noted, however, that mTORC 
inhibition and AMPK activation can disrupt expression of Oct4, Sox2, or Nanog and drive differentiation of certain 
germ layer lineages [6,31,32]. Hypoxia can also lead to changes in histone deacetylase (HDAC) activity and histone 
phosphorylation via AMPK [33,34], both of which alter gene expression, as summarized in Figure 2.  
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Figure 2: Diagram of Nutrient Diffusion and Stem Cell Signaling. The effects of various nutrient diffusants involved in energy production and 
metabolism are shown to also influence stem cell states and cellular differentiation.  
 
The multipotency of neural stem/progenitor cells is also generally preserved by a hypoxic environment, including 
both physiologic hypoxia (2-3%) and more severe hypoxia that would likely otherwise threaten viability of mature 
neuronal cells [8,35,36]. Many types of endogenous stem cells are known to reside in a hypoxic niche, including 
hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and neural stem cells (NSCs), which preserves 
tissue-specific endogenous stem cell populations [37]. Metabolic processes are also tightly coupled with the balance 
of stem cell populations in many types of tissues, and forced over-activation of mTORC (e.g., by deletion or 
inhibition of mTORC-inhibitors or constitutive expression of mTORC-activators) is known to shorten and accelerate 
the cell cycle in NSCs and HSCs [8], which, depending on the context and conditions, can diminish the repopulation 
capacity of HSCs or expand the proliferative capacity of NSCs [30,38]. Also, Lin28, acting through the PI3K-mTORC 
pathway, has been shown to accelerate cell proliferation in mouse PSCs [39]. 
 
In human PSCs, much evidence suggests that hypoxia tends to promote and preserve the pluripotent state, both 
preventing differentiation and enhancing reprogramming efficiency [15,19,31,34,40]. In fact, hypoxia has been shown 
to induce expression of many of the same genes used as reprogramming factors for pluripotency, including OCT4, 
SOX2, KLF4, NANOG, MYC, and LIN28 [15,41]. Because the choice of reprogramming factors substantially influences 
the quality and developmental potential of reprogrammed stem cells [42], environmental conditions of gasses, 
nutrients, and signaling factors will also influence these qualities, all of which are mediated by diffusion processes.  
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At greater distances from energy and nutrient sources where lower levels of nutrients will exist in the tissue due to 
diffusion limitations, cell pathways that favor pluripotent states are thus more likely to be active. This has an 
interesting correlate in cerebral organoids, where cortical neuron precursors migrate to and terminally differentiate at 
the external rim of the construct nearest the environmental oxygen supply, while deeper into the construct where 
oxygen is much more limited, neural stem cells may be better preserved and expand to supply future neural 
populations that fill the cortex. As organoid spheres expand, the hypoxic gradient can alter the position, timing, and 
fate of stem cells within the organoid and can also threaten cell viability. Diffusion modeling using Eq. 9 for oxygen & 
Eq. 12 for glucose has shown that central hypoxia in stem-cell-derived organoids is the main factor in limiting their 
maximal size and causing a central necrotic core if they grow beyond the limits of oxygen diffusion and metabolic 
consumption, though glucose could also become a limiting factor if feeding media is not replenished frequently 
enough [4].  
 
Environmental availability of oxygen is known to regulate sets of hypoxia inducible factors (HIFs), and HIFs regulate 
the expression of many genes involved in stem cell state, cellular development, and metabolic functions. At normal 
atmospheric oxygen concentration and pressure, oxygen induces hydroxylation and ubiquitinization of HIFs by 
prolyl-hydroxylases (PHDs) and the von-Hippel-Lindau protein (pVHL), respectively, which then targets α-subunits 
of HIFs for proteosomal degradation; with exposure to hypoxia, however, the α-subunits of HIFs are stabilized and 
bind to their respective nuclear translocators (e.g., HIF1β and HIF2β), where, in the nucleus, the HIFs then bind to 
various hypoxia-response elements for transcriptional regulation [43]. Similarly, enzymes like JmjC histone lysine 
demethylase (KDMs) are sensitive to specific oxygen concentrations and influence epigenetic regulation of the cell 
[44]. Both HIF1α and HIF2α are required for reprogramming to pluripotency, and the activity of either one alone 
activates the accompanying metabolic change to anaerobic glycolysis, although HIF2α activity in the late stages of 
reprogramming can inhibit the reprogramming process [12].  
 
Although ESCs and iPSCs are both pluripotent stem cells with equivalent functional potential and only minor 
epigenetic differences between them [45], further sub-states of pluripotency have emerged, including the concept of 
naïve versus primed pluripotent states. The naïve state tends to prefer oxidative metabolism (but utilizes both 
glycolytic and oxidative phosphorylation) and seems to represent the earliest state of embryonic development before 
implantation into the womb, while the primed pluripotent state favors glycolytic energy production and represents a 
more mature post-implantation state where DNA methylation patterns have already undergone significant changes 
[46,47]. Pluripotent cells can be coaxed into either state with various intrinsic and extrinsic factors [48,49]. Among the 
factors that promote a naïve state are the expression of Nanog and Klf4, both of which are promoted by hypoxia 
(Figure 2), again suggesting that a low oxygen environment likely favors the naïve pluripotent state, although it is 
not known if this alone can be sufficient to induce or maintain such a state in certain cells.  
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Hypoxia also activates other genes associated with stem cell states and cell development, including expression of 
Notch, WNT, and SHH, all via HIF1α [50,51] (Figure 2). It is not yet clear whether the mechanism of modulation of 
some hypoxia-responsive genes (like MYC, NANOG, or KLF4) is mediated directly by HIFs or other signaling 
pathways, but evidence suggests that some of these genes are regulated at least in part by non-coding microRNAs 
(miRNA). For example, MYC can be regulated by miRNA-210, which itself is controlled by both HIF1α and 2α [52], 
and Lin28 RNA-binding proteins inhibit let-7 miRNAs (which normally act as tumor suppressors), with the result 
that Lin28 and let-7 act as mutually antagonistic regulators of several downstream processes including glycolytic 
metabolism and cell growth via an mTORC-dependent pathway [53]. 
 
Several of the above factors are also involved in the early development of regional identity of neural tissue, including 
SHH, which generally drives ventralization, and WNT, which generally drives caudalization and dorsalization [5]. 
WNT and SHH activities are both increased under hypoxia via HIF1α, and both the WNT and SHH signaling 
pathways act through the β-catenin transducer, which activates effectors like FGF and Noggin to inhibit SMAD 
signaling pathways, as shown in Figure 3. SMAD inhibition is often used in directing differentiation of stem cells to a 
neuronal fate, which is typically done in culture with small molecule inhibitors of BMP and TGF-β that result in 
SMAD4-inhibition [54]. BMP and TGF-β can also activate Notch via SMAD1, as can hypoxia itself via HIF1α-
mediated signals [55], and TGF-β and SMAD4 can also exhibit reciprocal inhibition with MYC [56].  
 
 
Figure 3: Diagram of Diffusible Stem Cell Differentiation Signals. An overview is shown for how several signaling pathways can be used to 
guide differentiation from pluripotency to neuroglial lineage. Interestingly, many of the factors used in directed differentiation modulate the same 
molecular pathways used in oxygen signaling.  
 
Further evidence also shows that specific oxygen levels can have differential effects on germ layer specification and 
subsequent cell fate decisions, including whether neural progenitors progress to neurons or glia, depending on 
conditions and context that remain to be fully defined [41,57,58]. Exposure of spheroid cultures of human PSCs to 
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transient hypoxia (2% vs 21% O2), for example, was shown to drive a neural lineage over that of cardiovascular or 
musculoskeletal lineages and to change neuronal cell fate to a glial cell fate by acting through HIF1α to inhibit Lin28 
expression [41]. Other work, however, has shown that inhibition of mTORC limits pluripotency and proliferation 
while enhancing differentiation of human PSCs towards endodermal and mesodermal lineages [32]. Differentiation 
of neural crest stem cells (NCSCs) under hypoxic conditions (1-5% O2) has been shown to greatly expand and alter 
the possible array of mature neural subtypes, and activation of Notch signaling can promote maintenance of the 
neural precursor population and fate [55]. Physiologic hypoxia (2-3% O2) has also been found to promote 
neurogenesis while severe hypoxia (<1% O2) impeded both neurogenesis and gliogenesis [59]. 
 
Nitric oxide (NO) is another diffusible gas in tissues, which in the brain is produced by neural cells, glial cells, and 
vascular endothelial cells, both by constitutive and inducible mechanisms, particularly in response to ischemia in 
stroke, septic shock, or other poor perfusion events via various NO-synthase (NOS) isoforms as well as by other 
NOS-independent mechanisms [60,61]. NO can inhibit mitochondrial respiration and upregulate glycolysis and 
shunting through the pentose phosphate pathway, which may provide neuroprotection against free radical toxicity, 
mitochondrial damage, and apoptosis [61,62]. However, the production of NO in response to hypoxia or ischemia 
appears to depend on the particular conditions and timing of oxygen deprivation and reperfusion, and NO may play 
either protective or toxic roles depending on local conditions and tissue cell types, with neuroglial-produced NO 
playing a possible neurotoxic role while endothelial-produced NO may play a protective role by enhancing vascular 
perfusion. Consequently, both NO and NO-suppression have been suggested as therapeutic interventions for 
ischemic conditions in tissues of the brain and heart. Similarly, another gas affecting stem cell survival and 
differentiation is carbon dioxide (CO2), with evidence that higher levels of CO2 (10% versus the standard 5%) enabled 
the formation of larger and higher-quality neurospheres, induced significantly greater Nestin, Pax6, Sox2, and Foxg1 
expression in neuroprogenitor populations, and facilitated the genesis of glutamatergic, cholinergic, dopaminergic, 
and GABAergic neuronal subtypes [63]. Importantly, these data provide further evidence that cell populations in 3D 
tissue cultures are influenced not just by inward diffusion of outside nutrients, but also by factors diffusing 
outwardly from inside the tissue construct. 
 
Local variations in gas and nutrients within a tissue construct can therefore induce significant variations in cell and 
tissue identity, although it remains unknown to what extent the microenvironment of diffusant substances can 
regulate and guide essential developmental processes and cell states in the many different tissues of the human body. 
The effects of hypoxia on differentiation likely depend substantially not just on the exact amount of ambient oxygen 
or nutrient but also on genetic networks that are active or inactive in the cell and the phase of differentiation and cell 
maturity. A better understanding of oxygen concentrations within 3D cell cultures along with careful analysis of 
intermediate states of differentiation and development will thus help delineate the interactions of complex signaling 
cues and help resolve conflicting results.  
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2.3 The Influence of Nutrient Signaling and Metabolism on Neurological Disease 
 
Several factors involved in hypoxia signaling pathways are also known to play critical roles in neurological 
development and disease. For example, the tuberous sclerosis protein (TSC) complex, which acts as a tumor 
suppressor and, when mutated, causes the condition of tuberous sclerosis, acts to inhibit the mTOR complex, but is 
itself normally inhibited under normoxia. Subependymal nodules and giant cell astrocytomas associated with 
tuberous sclerosis are thought to be due to abnormal proliferation and migration of neural stem/progenitor cells 
(NSPCs) [64], and recent clinical trials show these types of tumors, and potentially others like glioblastoma and 
medulloblastoma, may be treated with mTORC-inhibitors like sirolimus, everolimus, dactolisib, XL765, or INK128 
[65,66]. Similarly, neurofibromatosis 1 is caused by disruption of the Ras-effector pathway which in turn can act 
through the TSC complex to exert its effects on mTORC, and the optic gliomas associated with this condition may 
also benefit from mTORC-inhibitors [67]. Moreover, mutations in pVHL cause von Hippel Lindau syndrome, with a 
constellation of tumors, vascular malformations, and cysts. Mutations or disruptions of SHH, or its downstream 
effector Patched1, can result in holoprosencephaly and craniofacial abnormalities. Metabolic impairments of 
mitochondrial function and susceptibility to oxidative stress are also suspected to play a major role in the 
pathogenesis of Parkinson’s diseases via mutant LRRK2, PARK2, PINK1, or Miro proteins [68]. 
 
Hypoxia is also known to inhibit numerous other signaling factors relevant to vascular development, cell migration, 
and tumor growth, including VEGF, EPO, and matrix metalloproteinase activity [51,69,70], and, as is seen in Figures 
2 and 3, many of these pathways overlap and intersect with each other. The mechanisms whereby the mitochondrial, 
nuclear, and cytoplasmic signaling work together (including causes and effects) to dictate metabolic preferences, 
energy production, oxidative protection, potency preservation, and cell fates still remains to be elucidated. Because 
metabolic functions and mitochondrial activity play essential roles in maintenance of and differentiation from stem 
cell states [71] researchers are obliged to be aware of difficulties that may arise in accurately modeling or restoring 
metabolic and mitochondrial diseases with patient-affected iPSCs compared with normal iPSCs.  
 
Pathological hypoxia in development is linked to several intractable neurological conditions, including 
encephalopathy, epilepsy, and cognitive impairments. Interestingly, however, exposure of many types of adult cells, 
including neurons and cardiomyocytes, to sub-lethal intervals of hypoxia can also enable cells to survive subsequent 
insults of more severe hypoxia, a phenomenon known as preconditioning, which may have implications for 
protecting organs and tissue from hypoxic-ischemic events [72]. The proper contexts and molecular mechanisms of 
this protective conditioning effect are still being fully elucidated [73], but this phenomenon may be useful for helping 
therapeutic cells and synthetic tissues survive after implantation into the body since the survival of these implanted 
tissues prior to vascularized integration is dependent on diffusion of nutrients from surrounding tissues. The 
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influence of gas and nutrient concentrations on gene expression and cell signaling pathways will also have many 
consequences for 3D tissue culture protocols and media formulations.  
 
Altogether, the collection of evidence shows that diffusant signaling is a crucial factor in all stem cell function, 
particularly for neural tissue development, and therefore an understanding of diffusion properties and profiles in 
tissue is essential to the study of tissue development. The ability of specific levels of gas, nutrients, and signaling 
factors to influence states of potency and differentiation means that diffusion can have significant effects on the 
composition, shape, and function of various tissues throughout the body. The rate and timing of stem cell self-
renewal, quiescence, and differentiation will tightly influence the size and capacity of the endogenous stem cell 
population in adult tissues and will also influence the quantity, balance, structure, and function of more specific cell 
identities in synthetic tissues. The mechanisms that regulate and carry out these functions, however, are not yet well 
understood despite the fact that they exert tremendous influence over numerous developmental and physiological 
processes.  
 
3. MODELS OF DIFFUSION IN TISSUE CONSTRUCTS 
 
The represented constants and variables for the following models are listed in the nomenclature summary (Table 1). 
In order to enable exact mapping of physical nutrient gradients through a 3D tissue construct at any given point in 
time, diffusion models were derived from the diffusion equation given by Fick’s laws, as applied to tissue constructs 
in the shape of a rectangular slab (s=1), a cylinder (s=2), or a sphere (s=3), and with a homogenous metabolic 
consumption rate of :  −  = 1
 
 

 
Analytic solutions describing diffusion of substances into 3D tissue constructs were recently described by the author, 
including novel models for diffusant substances that are metabolized by cells in the tissue construct (e.g., nutrients 
like glucose and oxygen) and for diffusants that are not metabolized by cells (e.g., certain cell signaling factors) as 
well as for both limited and unlimited diffusants (like glucose and oxygen, respectively), as summarized in Table 2. 
Approaches for finding various solutions to the diffusion equation and creating applicable models have been 
described by many authors [74,75,76,77], which is discussed in more detail in reference [4]. Equations describing 
outward diffusion from a tissue construct (e.g., for diffusing factors that are produced by or embedded in the tissue 
construct) can be derived in a similar manner with altered boundary conditions, the solutions of which are also 
presented in Table 2 as Eqs. 1-3. Typical values for diffusion parameters can be found in Table 3, and complete 
descriptions of boundary conditions and parameters for operating these models can be found in Table 5 and in 
reference [4]. 
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Because of difficulty in measuring gas or nutrient gradients through small, metabolically-active spheres, 
mathematical models provide a means for estimating diffusion gradients based on known diffusion mechanics and a 
few basic assumptions. The models are valid under the assumptions that cells are homogenously distributed and 
diffusivity is isotropic in the tissue construct, that diffusion occurs primarily along a single axis through a slab (1D 
case) or along the radial axis of a cylinder or sphere (2D or 3D cases), and, for the metabolic cases, that consumption 
rates of the diffusant (represented by ) are constant in the construct during each modeled time interval. In the case 
of slab constructs, the surface of the construct is at  = 0 and the thickness of the construct is represented by  = , 
whereas the surface of the radial constructs is at 
 =  and the center at 
 = 0, and solutions to the models are valid 
within the domain of 0 <  <	 or 0 < 
 <  . In models of outward diffusion,  is the concentration of 
substance that diffuses from the center of the tissue construct, and in models of inward diffusion,  is the initial 
concentration of substance at the outer edge of the tissue construct.  
 
In most cases, the initial concentration in a tissue construct () is zero, such as when newly-formed organoids are 
introduced into a media environment of glucose, oxygen, or other molecular factors, but in cases where the diffusant 
substance of interest is already present in the biomaterial, its initial concentration () is subtracted from the driving 
concentration of  and also subtracted from the total concentration . In other words, “” is replaced with “( −)”) and “” is replaced with “( − )”. In the cases of diffusion out of a tissue construct, it is assumed for simplicity 
that the diffusant is diluted to negligible levels once it leaves the tissue construct (e.g., as when the tissue construct 
volume is small relative to the surrounding media). If this assumption is not made, the diffusion into the media must 
also be accounted for and the total initial amount of diffusant must be spread over the total volume of the construct 
and the media at steady state, and the release of diffusant from the construct will influence its media concentration 
and by extension also influence the diffusive driving force over time. 
 
These analytic models thus allow mapping of concentration gradients through space and time for a variety of 
molecular signaling factors and nutrients into or out of 3D tissues in the shape of slabs, cylinders, or spheres. Of 
course, many more complex conditions and systems will require more complicated mathematical models that 
necessitate numerical approximations with computational software rather than complete analytic solutions, but this 
serves as an important foundation for mathematical descriptions of diffusion in most general cases of developing 
tissues. Finally, it is also important to note that actual gradient concentrations could deviate from predicted values 
with varying rates of metabolism, with varying inhomogeneities in the materials or cell densities, or with other 
pertinent forces on the tissue construct or diffusant molecules. 
 
Nomenclature Summary  Concentration  3.14159….   Initial concentration of diffusant at interface of  
source and tissue construct 
 Metabolic consumption rate for tissue construct             
                    (in units of mol/Ls, i.e.,  = ) ̅  Average concentration in tissue construct  Outer radius of a radial tissue construct   Initial baseline concentration in tissue construct   Maximal radius of a radial tissue construct 
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 !" #  Critical concentration $ Maximal radius as a function of time %&  Media concentration 
 Radial distance or spatial position  Diffusion coefficient  Density of cells in tissue construct '  Ordinary Derivative s  Spatial dimension of system   Partial Derivative Σ  Summation series in sigma notation erf  Error function  Time  erfc  Complementary error function  Thickness of linear tissue construct , 2.71828…. -  Volume of tissue construct ./(	) Bessel function of the first kind and order 0 - Volume of media around tissue construct 12 Eigenvalues  Spatial position or linear depth into construct  Metabolic rate per cell 3 Spatial position in Cartesian coordinates 4 Index term in sigma summation series 5 Spatial position in Cartesian coordinates 
 
Table 1: Nomenclature Summary of Variables, Functions, & Constant Parameters.  
 
 
Diffusion of limited diffusant out from tissue construct (no metabolism of diffusant)  
 1D       (Eq. 1) (, ) =  7erf8 √:;"< + ∑ ?erf 8(@2)A√:;" < − erf 8(@2)AB√:;" <CD2E F  
 
 2D       (Eq. 2) 
  (
, ) = @GHI ∑ ,(JK)L;"D2E MH(!JK)JKMN(IJK)  where 12 are found from Table 4.  
  
 3D       (Eq. 3) 
  (
, ) = @IGHO! P∑ (KQN)2 ,8KRS <L;"D2E sin 82O!I <W 
 
Diffusion of unlimited diffusant into tissue construct (no metabolism of diffusant) 
 1D       (Eq. 4) 
  (, ) =  7erfc 8 √:;"< + ∑ (−1)2B ?erf8(@2)A√:;" < − erf8(@2)AB√:;" <CD2E F  
  
2D       (Eq. 5) (
, ) =  71 − @I∑ ,(JK)L;"D2E MH(!JK)JKMN(IJK)F where 12 are found from Table 4.  
  
3D       (Eq. 6) 
  (
, ) =  + @IGHO! P∑ K2 ,8KRS <L;"D2E sin82O!I <W 
 
Diffusion of unlimited diffusant into tissue construct (with zero-order metabolism)  
 1D       (Eq. 7) 
  (, ) =  + 22 −  − @GHO ∑ 2 ,8KRY <L;"D2E sin 84 2−2GH< 
  
2D       (Eq. 8) 
  (
, ) = GH!LIL + @GHO P∑ K2 ,8KRS <L;"D2E sin 84 !LIL<W where  = Z!L:;  
  
3D       (Eq. 9) 
  (
, ) = GH!LIL + @GHO P∑ K2 ,8KRS <L;"D2E sin 84 !LIL<W where  = Z!L[;  
 
Diffusion of limited diffusant into tissue construct (with zero-order metabolism) 
 1D       (Eq. 10) 
   (, ) = 
14 
 
 −  - - − ̅ - (- + - ) + @2 − \2  − 
- - − ̅ - (- + - )
−	2  −  - - − ̅ - (- + - ) ] 14 ,82OA <L;"D2E sin _^4
`8  −  - - − ̅ - (- + - ) − 2  −  - - − ̅ - (- + - ) bc 
where ̅ =  P1 − dOL∑ (@2)L ,8(LKeN)RLY <L;"D2E W and f = g2h8i− -j-−k -j(-+-j)<  
 
 2D       (Eq. 11) (
, ) = (
 −  + $)@4
+ 2  −  - - − ̅ - (- + - ) mnn
no]−124 ,p
Z"(2O)L:GH:Z" qrqsG̅ :qr(qsBqr)tD2E sin p 4(
 −  + $)
@
4  −  - - − ̅ - (- + - )tuvv
vw
 
  where ̅ =  71 − ∑ :(JKI)L ,JKL;"D2E F and f = g48i− -j-−k -j(-+-j)<  
 
3D       (Eq. 12) (
, ) = 
Z(!IsxyBIsxy$)L[; + @8GHZ" zrzsG̅ zr(zsQzr)<O mnn
o∑ K2 ,{ e|$(KR)
L}~He}|$ zrzse~ }zr(zsQzr)D2E sin  Z2O(!IsxyBIsxy$)L[;8GHZ" zrzsG̅ zr(zsQzr)<uvv
w
   
  where ̅ =  P1 − [OL∑ 2L ,8KRS <L;"D2E W and f = g68i− -j-−̅ -j(-+-j)<  
 
Table 2: Analytic Models of Diffusion. Twelve different equations are given for modeling several different scenarios of diffusion of nutrients and 
signaling factors in 3D tissue constructs. 
 
 
Typical Ranges of Diffusant Parameters in Tissue Systems 
Diffusion Coefficient (D) 10-8  to  10-11  m2/s 
Initial Concentration (C) 0.01  to  100  mM 
Metabolic Rate of Cell (m) 10-15  to  10-18  mol/s 
 
Table 3: Parameter Ranges for Diffusing Molecules in Tissue Systems. Typical ranges of important parameters in tissue diffusion systems are 
provided [4]. These parameters can be used to predict the maximal viable size of a tissue construct based on limitations of diffusing nutrients, 
where the maximal depth of a tissue construct is `@GH;Z  and where the metabolic rate of a tissue construct () can be determined from the average 
density of cells () multiplied by the average metabolic rate of the cells ().  
 
 
Bessel Function Roots 
 .() (nth roots) 12 for .(12R) 
n=1 2.4048 2.4048/R 
n=2 5.5201 5.5201/R 
n=3 8.6537 8.6537/R 
n=4 11.7915 11.7915/R 
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n=5 14.9309 14.9309/R 
n=6 18.0711 18.0711/R 
n=7 21.2116 21.2116/R 
n=8 24.3525 24.3525/R 
n=9 27.4935 27.4935/R 
n=10 30.6346 30.6346/R 
Table 4: Bessel Function Roots. The first ten roots of the first kind of Bessel function of order zero, used for cylindrical diffusion solutions. 
 
 
Eq. 1 (, 0) =  for 0 ≤  ≤   
 (0, ) = 0 for  > 0 (∞, )/	 = 0 
 
Eq. 2 (
, 0) =  for 0 ≤ 
 ≤  (, ) = 0 for  > 0  (0, )/
	 = 0 
 
Eq. 3 (
, 0) =  for 0 ≤ 
 ≤  (, ) = 0 for  > 0  (0, )/
	 = 0 lim!→(
, ) = i4',' 
 
Eq. 4 (, 0) = 0 for 0 ≤  ≤   
 (0, ) =  for  > 0 (∞, )/	 = 0 
  
Eq. 5 (
, 0) = 0 for 0 ≤ 
 ≤  (, ) =  for  > 0  (0, )/
	 = 0 
  
Eq. 6 (
, 0) = 0 for 0 ≤ 
 ≤  (, ) =  for  > 0  (0, )/
	 = 0 lim!→(
, ) = i4',' 
 
Eq. 7 (, 0) = 0 for 0 ≤  ≤   
 (, ) = 0   
 (0, ) =   
  
Eq. 8 (
, 0) = 0 for 0 ≤ 
 ≤  (, ) =   (0, ) = 0 
 
Eq. 9 (
, 0) = 0 for 0 ≤ 
 ≤  
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(, ) =   (0, ) = 0 
 
Eq. 10 (, 0) = 0 for 0 ≤  ≤   
 (, ) = 0  
 (0, ) =  − qrqs − ̅ qr(qsBqr) 
 
Eq. 11 (
, 0) = 0 for 0 ≤ 
 ≤  (, ) =  −  qrqs − ̅ qr(qsBqr)  (0, ) = 0  
 
Eq. 12 (
, 0) = 0 for 0 ≤ 
 ≤  (, ) =  −  qrqs − ̅ qr(qsBqr)  (0, ) = 0  
 
Table 5: Diffusion Model Boundary Conditions. The initial and boundary conditions of each respective equation are provided.  
 
 
4. CONCLUSIONS 
 
With advancing abilities to create tissue and organoid structures from stem cells and biomaterials, and with new and 
ongoing discoveries of how gas, nutrient, and signaling factor concentrations produce differential effects on stem cell 
state and function, a novel role of diffusion modeling has emerged for study of stem cell functions and 
developmental processes in three-dimensional (3D) tissues. Ideal compositions for formation of targeted tissue 
structures, cellular identities, and functional neural networks remain to be explored, and in the course of these 
endeavors it is important to recognize that the ability to properly guide differentiation of stem cells and development 
of tissues for therapeutic use is strongly dependent on how gasses, nutrients, and signaling factors diffuse in cultured 
tissue constructs. In fact, growth and development of cellular tissues both are influenced by and influence the 
internal diffusion dynamics as a reciprocal interaction. This work describes many complex interactions of diffusant 
substances in stem cell biology and presents several unique analytic models for understanding diffusion phenomena 
in tissue constructs, thereby enabling modeling of oxygen and nutrient delivery to cells and study of mass transport 
and spatial gradients that form in 3D tissue constructs under a variety of conditions. The use of engineered 
combinations of cells, biomaterials, and biochemical diffusing factors is likely to one day enable guided 
differentiation and detailed control of cellular organization in synthetic tissue constructs. These concepts and 
investigations will therefore have significant impact on regenerative approaches for many otherwise disparate 
diseases and injuries, particularly those of the nervous system, including stroke, spinal cord injury, cancer, 
neurodegenerative diseases, and many other neurogenetic syndromes and developmental abnormalities. 
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SUPPLEMENTAL INFORMATION 
 
A Matlab script with a simple graphical user interface is provided as supplementary material at 
http://dx.doi.org/10.1089/scd.2017.0066 which can solve the diffusion models in tissue constructs by simply inputting 
appropriate parameters of the system. Instructions for operating the files are also provided.  
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